Cargando…
Efficacy of Insulin Analogs in Achieving the Hemoglobin A(1c) Target of <7% in Type 2 Diabetes: Meta-analysis of randomized controlled trials
OBJECTIVE: Insulin analogs are increasingly used in patients with type 2 diabetes. We compared the effect of basal, biphasic, prandial, and basal-bolus insulin regimens with insulin analogs to reach the hemoglobin A(1c) (HbA(1c)) target of <7% in people with type 2 diabetes. RESEARCH DESIGN AND M...
Autores principales: | Giugliano, Dario, Maiorino, Maria Ida, Bellastella, Giuseppe, Chiodini, Paolo, Ceriello, Antonio, Esposito, Katherine |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024378/ https://www.ncbi.nlm.nih.gov/pubmed/21216850 http://dx.doi.org/10.2337/dc10-1710 |
Ejemplares similares
-
Metabolic Syndrome and Risk of Cancer: A systematic review and meta-analysis
por: Esposito, Katherine, et al.
Publicado: (2012) -
Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney
por: Giugliano, Dario, et al.
Publicado: (2020) -
The residual cardiorenal risk in type 2 diabetes
por: Giugliano, Dario, et al.
Publicado: (2021) -
Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies
por: Longo, Miriam, et al.
Publicado: (2020) -
2010 Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement
por: Hanas, Ragnar, et al.
Publicado: (2010)